Patents by Inventor Nathan Crouther

Nathan Crouther has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12178617
    Abstract: A system and method to provide guidance for diabetes therapy includes determining glycemic risks based on an analysis of glucose data. The analysis includes visualization of a glucose median, the variability of glucose in a patient, and the risk of hypoglycemia. An Advanced Daily Patterns report includes a visualization of an ambulatory glucose profile and a glucose control measure. The glucose control measure provides a highly visible and understandable display of the glucose condition of a patient visually expressed in the categories of low glucose, median glucose, and glucose variability.
    Type: Grant
    Filed: July 1, 2019
    Date of Patent: December 31, 2024
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Timothy C. Dunn, Kenneth J. Doniger, Glenn Berman, Gary A. Hayter, Erwin S. Budiman, Daniel M. Bernstein, Nathan Crouther
  • Publication number: 20240407736
    Abstract: A system and method to provide guidance for diabetes therapy includes determining glycemic risks based on an analysis of glucose data. The analysis includes visualization of a glucose median, the variability of glucose in a patient, and the risk of hypoglycemia. An Advanced Daily Patterns report includes a visualization of an ambulatory glucose profile and a glucose control measure. The glucose control measure provides a highly visible and understandable display of the glucose condition of a patient visually expressed in the categories of low glucose, median glucose, and glucose variability.
    Type: Application
    Filed: August 21, 2024
    Publication date: December 12, 2024
    Inventors: Timothy C. DUNN, Kenneth J. DONIGER, Glenn BERMAN, Gary A. HAYTER, Erwin S. BUDIMAN, Daniel M. BERNSTEIN, Nathan CROUTHER
  • Patent number: 12102454
    Abstract: A system and method to provide guidance for diabetes therapy includes determining glycemic risks based on an analysis of glucose data. The analysis includes visualization of a glucose median, the variability of glucose in a patient, and the risk of hypoglycemia. An Advanced Daily Patterns report includes a visualization of an ambulatory glucose profile and a glucose control measure. The glucose control measure provides a highly visible and understandable display of the glucose condition of a patient visually expressed in the categories of low glucose, median glucose, and glucose variability.
    Type: Grant
    Filed: May 11, 2022
    Date of Patent: October 1, 2024
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Timothy C. Dunn, Kenneth J. Doniger, Glenn Berman, Gary A. Hayter, Erwin S. Budiman, Daniel M. Bernstein, Nathan Crouther
  • Publication number: 20220280122
    Abstract: A system and method to provide guidance for diabetes therapy includes determining glycemic risks based on an analysis of glucose data. The analysis includes visualization of a glucose median, the variability of glucose in a patient, and the risk of hypoglycemia. An Advanced Daily Patterns report includes a visualization of an ambulatory glucose profile and a glucose control measure. The glucose control measure provides a highly visible and understandable display of the glucose condition of a patient visually expressed in the categories of low glucose, median glucose, and glucose variability.
    Type: Application
    Filed: May 11, 2022
    Publication date: September 8, 2022
    Inventors: Timothy C. DUNN, Kenneth J. DONIGER, Glenn BERMAN, Gary A. HAYTER, Erwin S. BUDIMAN, Daniel M. BERNSTEIN, Nathan CROUTHER
  • Patent number: 11331051
    Abstract: A system and method to provide guidance for diabetes therapy includes determining glycemic risks based on an analysis of glucose data. The analysis includes visualization of a glucose median, the variability of glucose in a patient, and the risk of hypoglycemia. An Advanced Daily Patterns report includes a visualization of an ambulatory glucose profile and a glucose control measure. The glucose control measure provides a highly visible and understandable display of the glucose condition of a patient visually expressed in the categories of low glucose, median glucose, and glucose variability.
    Type: Grant
    Filed: December 15, 2020
    Date of Patent: May 17, 2022
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Timothy C. Dunn, Kenneth J. Doniger, Glenn Berman, Gary A. Hayter, Erwin S. Budiman, Daniel M. Bernstein, Nathan Crouther
  • Publication number: 20220116395
    Abstract: Systems, devices, and methods are provided that allow the authentication of devices within analyte monitoring systems. The analyte monitoring systems can be in vivo systems and can include a sensor control device with a sensor and accompanying circuitry, as well as a reader device for communicating with the sensor control device. The analyte monitoring systems can interface with a trusted computer system located at a remote site. Numerous techniques of authentication are disclosed that can enable the detection of counterfeit components, such as a counterfeit sensor control device.
    Type: Application
    Filed: December 23, 2021
    Publication date: April 14, 2022
    Inventors: Michael R. Love, Mark Sloan, Glenn Berman, Nathan Crouther, Gil Porat
  • Publication number: 20220075864
    Abstract: Systems, devices, and methods are provided for the control of interfacing between applications that facilitate the monitoring of diabetes running on a mobile device, including the authentication of a third party user interface application by a sensor interface application. Control of the display of current analyte levels and critical events is also provided.
    Type: Application
    Filed: November 16, 2021
    Publication date: March 10, 2022
    Inventors: Glenn Berman, Nathan Crouther, Michael R. Love, Mark Sloan
  • Publication number: 20220047812
    Abstract: Systems for the delivery of insulin to a patient, the system comprising: a continuous glucose sensor configured to provide a glucose level signal representative of sensed glucose; an insulin delivery device configured to deliver insulin in response to delivery control signals at a basal rate and as a bolus; and a controller programmed to receive the sensor glucose level signal and to provide a delivery control signal to an insulin delivery device to suspend a basal delivery rate during the provision of a bolus delivery and to automatically resume a preprogrammed basal delivery rate after a selected event.
    Type: Application
    Filed: October 28, 2021
    Publication date: February 17, 2022
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Erwin S. Budiman, Gary A. Hayter, Nathan Crouther, Marc B. Taub, Wesley Scott Harper, Charles Wei
  • Patent number: 11185632
    Abstract: Systems comprising: an analyte sensor for providing an analyte signal representative of an analyte level; a controller in data communication with the analyte sensor and programmed to provide a recommended medication dose based on the analyte level and a medication type, the controller comprising a user interface for inputting the medication type; and a model-based safety mechanism integrated with the controller for evaluating the recommended medication dose. Wherein the model-based safety mechanism overrides the recommended medication dose and provides a safety medication dose when the model-based safety mechanism detects a risk of insulin deprivation.
    Type: Grant
    Filed: March 4, 2020
    Date of Patent: November 30, 2021
    Assignee: Abbott Diabetes Care, Inc.
    Inventors: Erwin S. Budiman, Gary A. Hayter, Nathan Crouther, Marc B. Taub, Wesley Scott Harper, Charles Wei
  • Patent number: 11122043
    Abstract: Systems, devices, and methods are provided that allow the authentication of devices within analyte monitoring systems. The analyte monitoring systems can be in vivo systems and can include a sensor control device with a sensor and accompanying circuitry, as well as a reader device for communicating with the sensor control device. The analyte monitoring systems can interface with a trusted computer system located at a remote site. Numerous techniques of authentication are disclosed that can enable the detection of counterfeit components, such as a counterfeit sensor control device.
    Type: Grant
    Filed: October 3, 2018
    Date of Patent: September 14, 2021
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Michael R. Love, Mark Sloan, Glenn Berman, Nathan Crouther, Gil Porat
  • Publication number: 20210225524
    Abstract: Systems, devices, and methods are provided that allow detection of episodes in analyte measurement, prompting a patient to self-report possible causes for the episodes. Correlation of possible causes with detected episodes assists patient behavior modification to reduce the occurrence of episodes.
    Type: Application
    Filed: April 9, 2021
    Publication date: July 22, 2021
    Inventors: Gary A. Hayter, Timothy C. Dunn, Nathan Crouther, Daniel M. Bernstein, Eric L. Davis
  • Patent number: 11004566
    Abstract: Systems, devices, and methods are provided that allow detection of episodes in analyte measurement, prompting a patient to self-report possible causes for the episodes. Correlation of possible causes with detected episodes assists patient behavior modification to reduce the occurrence of episodes.
    Type: Grant
    Filed: July 5, 2016
    Date of Patent: May 11, 2021
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Gary A. Hayter, Timothy C. Dunn, Nathan Crouther, Daniel M. Bernstein, Eric L. Davis
  • Publication number: 20210100515
    Abstract: A system and method to provide guidance for diabetes therapy includes determining glycemic risks based on an analysis of glucose data. The analysis includes visualization of a glucose median, the variability of glucose in a patient, and the risk of hypoglycemia. An Advanced Daily Patterns report includes a visualization of an ambulatory glucose profile and a glucose control measure. The glucose control measure provides a highly visible and understandable display of the glucose condition of a patient visually expressed in the categories of low glucose, median glucose, and glucose variability.
    Type: Application
    Filed: December 15, 2020
    Publication date: April 8, 2021
    Inventors: Timothy C. Dunn, Kenneth J. Doniger, Glenn Berman, Gary A. Hayter, Erwin S. Budiman, Daniel M. Bernstein, Nathan Crouther
  • Publication number: 20210093251
    Abstract: Systems, devices, and methods for detecting, measuring and classifying meals for an individual based on analyte measurements. These results and related information can be presented to the individual to show the individual which meals are causing the most severe analyte response. These results can be organized and categorized based on preselected criteria or previous meals and results so as to organize and present the results in a format with reference to glucose as the monitored analyte. Various embodiments disclosed herein relate to methods, systems, and software applications intended to engage an individual by providing direct and timely feedback regarding the individual's meal-related glycemic response.
    Type: Application
    Filed: December 15, 2020
    Publication date: April 1, 2021
    Inventors: Gary A. Hayter, Timothy C. Dunn, Nathan Crouther
  • Patent number: 10888272
    Abstract: Systems, devices, and methods for detecting, measuring and classifying meals for an individual based on analyte measurements. These results and related information can be presented to the individual to show the individual which meals are causing the most severe analyte response. These results can be organized and categorized based on preselected criteria or previous meals and results so as to organize and present the results in a format with reference to glucose as the monitored analyte. Various embodiments disclosed herein relate to methods, systems, and software applications intended to engage an individual by providing direct and timely feedback regarding the individual's meal-related glycemic response.
    Type: Grant
    Filed: July 8, 2016
    Date of Patent: January 12, 2021
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Gary A. Hayter, Timothy C. Dunn, Nathan Crouther
  • Publication number: 20200197607
    Abstract: Systems comprising: an analyte sensor for providing an analyte signal representative of an analyte level; a controller in data communication with the analyte sensor and programmed to provide a recommended medication dose based on the analyte level and a medication type, the controller comprising a user interface for inputting the medication type; and a model-based safety mechanism integrated with the controller for evaluating the recommended medication dose. Wherein the model-based safety mechanism overrides the recommended medication dose and provides a safety medication dose when the model-based safety mechanism detects a risk of insulin deprivation.
    Type: Application
    Filed: March 4, 2020
    Publication date: June 25, 2020
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Erwin S. Budiman, Gary A. Hayter, Nathan Crouther, Marc B. Taub, Wesley Scott Harper, Charles Wei
  • Patent number: 10583251
    Abstract: Safety features are applied to an integrated insulin delivery system to enhance safety by controlling medication delivery including the automatic resumption of basal rate after a particular event, such as termination of a bolus, expiration of a time period, delayed resumption after the bolus has terminated, IOB comparison, and others. Other safety features include overriding a delivery control that may result in hypoglycemia, and terminating an extended bolus or temporary basal rate in view of a glucose signal indicating imminent carbohydrate deficiency. In another feature, an automatic resumption of a basal delivery rate is programmed into the delivery device to avoid the possibility of complete loss of delivery of insulin in the event that communication with the delivery device is disrupted.
    Type: Grant
    Filed: October 24, 2018
    Date of Patent: March 10, 2020
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Erwin S. Budiman, Gary A. Hayter, Nathan Crouther, Marc B. Taub, Wesley Scott Harper, Charles Wei
  • Publication number: 20200015756
    Abstract: A system and method to provide guidance for diabetes therapy includes determining glycemic risks based on an analysis of glucose data. The analysis includes visualization of a glucose median, the variability of glucose in a patient, and the risk of hypoglycemia. An Advanced Daily Patterns report includes a visualization of an ambulatory glucose profile and a glucose control measure. The glucose control measure provides a highly visible and understandable display of the glucose condition of a patient visually expressed in the categories of low glucose, median glucose, and glucose variability.
    Type: Application
    Filed: July 1, 2019
    Publication date: January 16, 2020
    Inventors: Timothy C. Dunn, Kenneth J. Doniger, Glenn Berman, Gary A. Hayter, Erwin S. Budiman, Daniel M. Bernstein, Nathan Crouther
  • Publication number: 20190354674
    Abstract: Systems, devices, and methods are provided for the control of interfacing between applications that facilitate the monitoring of diabetes running on a mobile device, including the authentication of a third party user interface application by a sensor interface application. Control of the display of current analyte levels and critical events is also provided.
    Type: Application
    Filed: June 7, 2019
    Publication date: November 21, 2019
    Inventors: Glenn Berman, Nathan Crouther, Michael R. Love, Mark Sloan
  • Patent number: D994695
    Type: Grant
    Filed: August 13, 2021
    Date of Patent: August 8, 2023
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Gary A. Hayter, Timothy C. Dunn, Nathan Crouther, Daniel M. Bernstein, Eric L. Davis